Please note that this session is not accredited for continuing pharmacy education credit.

Course Description

Novel therapies, such as gene and cell therapy, are growing in availability and meeting medical needs for previously uncurable conditions. These important and life-saving options are associated with high initial costs raising predictability, affordability, and accessibility concerns for managed care organizations. This session will discuss various perspectives on alternative payment models, financial tools, and policy initiatives that mitigate risk and improve access to these durable cures.